Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-23

Clinical Trial Update: Endocannabinoids in End Stage Renal Disease

View source ↗

Summary

A completed clinical trial evaluating the role of endocannabinoids in patients with end-stage renal disease, with attention to nutritional parameters.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indiana University | Conditions: End Stage Renal Disease, Nutrition | Status: COMPLETED